Article Details
Retrieved on: 2022-11-03 21:37:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AZD8601, an mRNA therapy that encoded vascular endothelial growth factor (VEGF-A), was a Phase II drug candidate. The drug was injected directly into ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here